rApp Observability: Causal Attribution of KPI Changes to rApp Actions in O-RAN Non-RT RIC
IEEE Networking Letters · 2026 · 8 · 194-198
DOI: 10.1109/lnet.2026.3700191 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE Networking Letters, 2026. Verfasst von Roberto Riggio. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Concurrent rApps (third-party applications running atop the Non-RT RIC) introduce a fundamental observability gap: when a Key Performance Indicator (KPI) changes, operators cannot systematically determine which rApp action caused it. Existing O-RAN conflict mitigation operates proactively or reactively within the control loop but offers no post-hoc causal attribution. We propose an observability architecture for the Non-RT RIC that captures timestamped rApp actions across the R1, A1, and O1 interfaces, aligns them with KPI time series, and applies a causal attribution methodology combining changepoint detection, Granger causality, conditional intervention effect, and temporal precedence scoring. Evaluation with three concurrent rApps over a simulated multi-cell 5G setup, across three scenarios of increasing difficulty, shows that the combined method achieves high accuracy when actions are temporally or spatially separated and consistently places the causal rApp within the top-2 candidates under concurrent overlapping actions on shared cells.
Zitieren
APA
Riggio, R. (2026). rApp Observability: Causal Attribution of KPI Changes to rApp Actions in O-RAN Non-RT RIC. IEEE Networking Letters, 8, 194-198. https://doi.org/10.1109/lnet.2026.3700191
Vancouver
Riggio R. rApp Observability: Causal Attribution of KPI Changes to rApp Actions in O-RAN Non-RT RIC. IEEE Networking Letters. 2026;8:194-198. doi:10.1109/lnet.2026.3700191
BibTeX
@article{Riggio2026,
author = {Riggio, Roberto},
title = {rApp Observability: Causal Attribution of KPI Changes to rApp Actions in O-RAN Non-RT RIC},
journal = {IEEE Networking Letters},
year = {2026},
volume = {8},
pages = {194--198},
doi = {10.1109/lnet.2026.3700191}
}
EUVIMED